Bicycle Therapeutics PLC (BCYC)
14.68
-0.32
(-2.13%)
USD |
NASDAQ |
Dec 20, 16:00
14.68
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Shareholders Equity (Quarterly): 831.03M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Autolus Therapeutics PLC | 476.96M |
| Mereo BioPharma Group PLC | 72.54M |
| TC BioPharm (Holdings) PLC | 2.535M |
| Adaptimmune Therapeutics PLC | 79.99M |
| NuCana PLC | 5.818M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 996.75M |
| Total Liabilities (Quarterly) | 165.71M |
| Current Ratio | 17.13 |
| Net Debt Paydown Yield | 0.39% |